NTLA
Price
$19.72
Change
-$1.21 (-5.78%)
Updated
Sep 6 closing price
54 days until earnings call
TERN
Price
$7.81
Change
+$0.35 (+4.69%)
Updated
Sep 6 closing price
60 days until earnings call
Ad is loading...

NTLA vs TERN

Header iconNTLA vs TERN Comparison
Open Charts NTLA vs TERNBanner chart's image
Intellia Therapeutics
Price$19.72
Change-$1.21 (-5.78%)
Volume$1.42M
CapitalizationN/A
Terns Pharmaceuticals
Price$7.81
Change+$0.35 (+4.69%)
Volume$1.35M
CapitalizationN/A
View a ticker or compare two or three
NTLA vs TERN Comparison Chart
Loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
NTLA vs. TERN commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NTLA is a Hold and TERN is a Hold.

COMPARISON
Comparison
Sep 08, 2024
Stock price -- (NTLA: $20.94 vs. TERN: $7.47)
Brand notoriety: NTLA and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NTLA: 64% vs. TERN: 55%
Market capitalization -- NTLA: $2B vs. TERN: $549.6M
NTLA [@Biotechnology] is valued at $2B. TERN’s [@Biotechnology] market capitalization is $549.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $584.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NTLA’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • NTLA’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, NTLA is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NTLA’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 4 bullish TA indicator(s).

  • NTLA’s TA Score: 4 bullish, 6 bearish.
  • TERN’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, TERN is a better buy in the short-term than NTLA.

Price Growth

NTLA (@Biotechnology) experienced а -8.96% price change this week, while TERN (@Biotechnology) price change was -2.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.71%. For the same industry, the average monthly price growth was +3.67%, and the average quarterly price growth was -3.87%.

Reported Earning Dates

NTLA is expected to report earnings on Oct 31, 2024.

TERN is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-2.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($2B) has a higher market cap than TERN($550M). TERN YTD gains are higher at: 15.100 vs. NTLA (-31.322). TERN has higher annual earnings (EBITDA): -107.31M vs. NTLA (-514.18M). NTLA has more cash in the bank: 691M vs. TERN (225M). TERN has less debt than NTLA: TERN (249K) vs NTLA (106M). NTLA has higher revenues than TERN: NTLA (46M) vs TERN (0).
NTLATERNNTLA / TERN
Capitalization2B550M364%
EBITDA-514.18M-107.31M479%
Gain YTD-31.32215.100-207%
P/E RatioN/AN/A-
Revenue46M0-
Total Cash691M225M307%
Total Debt106M249K42,570%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
95
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NTLATERN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
79%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
NTLA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OAKEX20.530.05
+0.24%
Oakmark International Small Cap Investor
GTCIX17.370.02
+0.12%
Glenmede Quant International Equity
TRSZX18.88-0.08
-0.42%
T. Rowe Price Mid-Cap Index Z
JRSDX11.26-0.05
-0.44%
JH Adaptive Risk Mgd U.S. Eq D
FSPHX31.37-0.27
-0.85%
Fidelity Select Health Care

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with BEAM. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
-1.55%
BEAM - NTLA
75%
Closely correlated
+0.46%
EDIT - NTLA
75%
Closely correlated
-0.43%
CRSP - NTLA
71%
Closely correlated
+0.58%
VCYT - NTLA
69%
Closely correlated
+0.76%
PRME - NTLA
67%
Closely correlated
-2.46%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with PRME. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+1.91%
PRME - TERN
40%
Loosely correlated
-2.46%
RCUS - TERN
40%
Loosely correlated
-1.04%
NTLA - TERN
39%
Loosely correlated
-1.55%
AMLX - TERN
39%
Loosely correlated
+5.50%
ALT - TERN
38%
Loosely correlated
-1.62%
More